NuVasive Up 20% After Q1 Earnings

Shares of NuVasive

are soaring on Tuesday after the company reported strong first-quarter earnings on Monday. At last check, NUVA was up nearly 20% to $19.82. Volume is running at 873% the daily average. The company reported Q1 non-GAAP earnings per share of $0.20. This compared to analysts' consensus EPS estimates of $0.18. Revenues for the period came in at $151.7 million. This came in well ahead of Wall Street estimates of $143.5 million. After today's rally, NUVA shares have now risen nearly 57% in 2012, although the stock is still down more than 36% over the last 52-weeks. NuVasive, Inc. (NuVasive) is a medical device company. NuVasive focuses on developing minimally disruptive surgical products and procedures for the spine.